Clinical Trials Browser

Phase 2 × Diphtheria-Tetanus Vaccine × 1 year × Clear all

NCT06639074 2025-10-02

Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial

Phase 2 Recruiting

GynecologicSarcoma

Advanced Fallopian Tube Carcinoma

NCT05096481 2025-09-09

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Phase 2 Recruiting

Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma